As a result, the up‐regulation of RIPK3 and MLKL and down‐regulation of its negative regulators may indicate enhanced RIPK3‐mediated necroptosis in the development of MCT‐induced PAH. The gene discussed is RIPK3; the disease is pulmonary arterial hypertension.